Purchases and Sales Made in Q4 2021 in Outlook Therapeutics, Inc. (OTLK)
This table provides information about the institutional ownership of Outlook Therapeutics, Inc. (OTLK) during Q4 2021. The information is specifically focused on institutions that hold shares of Outlook Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-39.8K- 26.33% |
$50.5K - $88.7K
|
111K
$239K
|
|
|
Feb 14, 2022
Q4 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-46.7K- 37.52% |
$59.3K - $104K
|
77.8K
$167K
|
|
|
Mar 03, 2022
Q4 2021
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-47.6KClosed |
$60.4K - $106K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-61.5K- 34.45% |
$78.1K - $137K
|
117K
$252K
|
|
|
Feb 14, 2022
Q4 2021
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-80.5K- 72.41% |
$102K - $179K
|
30.6K
$65.9K
|
|
|
Feb 14, 2022
Q4 2021
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-145KClosed |
$184K - $323K
|
0
$0
|
|
|
Jan 26, 2022
Q4 2021
|
Lincoln National Corp
|
SELL
|
- |
-150K- 59.22% |
$191K - $335K
|
103K
$222K
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-195K- 82.89% |
$247K - $434K
|
40.2K
$86.4K
|